Kathy L. Hibbs Sells 38,548 Shares of 23andMe Holding Co. (NASDAQ:ME) Stock

23andMe Holding Co. (NASDAQ:MEGet Free Report) insider Kathy L. Hibbs sold 38,548 shares of the firm’s stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $0.46, for a total transaction of $17,732.08. Following the sale, the insider now directly owns 1,252,315 shares of the company’s stock, valued at $576,064.90. The transaction was disclosed in a document filed with the SEC, which is available at this link.

23andMe Price Performance

NASDAQ:ME opened at $0.40 on Friday. 23andMe Holding Co. has a 1-year low of $0.40 and a 1-year high of $2.32. The firm has a 50-day moving average of $0.63 and a two-hundred day moving average of $0.80.

23andMe (NASDAQ:MEGet Free Report) last issued its quarterly earnings results on Wednesday, February 7th. The company reported ($0.17) EPS for the quarter. 23andMe had a negative net margin of 210.48% and a negative return on equity of 52.99%. The business had revenue of $44.75 million during the quarter, compared to analysts’ expectations of $56.30 million.

Institutional Trading of 23andMe

A number of hedge funds and other institutional investors have recently made changes to their positions in ME. Advisor Group Holdings Inc. raised its position in shares of 23andMe by 21.8% during the 1st quarter. Advisor Group Holdings Inc. now owns 54,620 shares of the company’s stock worth $210,000 after purchasing an additional 9,765 shares during the period. Swiss National Bank lifted its holdings in 23andMe by 64.8% in the first quarter. Swiss National Bank now owns 219,400 shares of the company’s stock worth $840,000 after purchasing an additional 86,300 shares during the period. ProShare Advisors LLC grew its position in 23andMe by 26.1% in the 1st quarter. ProShare Advisors LLC now owns 21,854 shares of the company’s stock valued at $84,000 after buying an additional 4,525 shares in the last quarter. JPMorgan Chase & Co. increased its stake in 23andMe by 83.0% during the 1st quarter. JPMorgan Chase & Co. now owns 86,111 shares of the company’s stock valued at $330,000 after buying an additional 39,066 shares during the period. Finally, Bank of New York Mellon Corp lifted its stake in shares of 23andMe by 168.5% in the 1st quarter. Bank of New York Mellon Corp now owns 91,142 shares of the company’s stock worth $349,000 after acquiring an additional 57,198 shares during the period. Institutional investors own 28.23% of the company’s stock.

23andMe Company Profile

(Get Free Report)

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.

Featured Stories

Insider Buying and Selling by Quarter for 23andMe (NASDAQ:ME)

Receive News & Ratings for 23andMe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 23andMe and related companies with MarketBeat.com's FREE daily email newsletter.